JW Pharmaceutical Corp (001067) — Cash Flow Reinvestment Rate
JW Pharmaceutical Corp (001067) has a Cash Flow Reinvestment Rate of 0.44x as of September 2025, reinvesting ₩20.68 Billion (capex ₩9.80 Billion plus investments ₩10.88 Billion) from operating cash flow of ₩46.92 Billion. Explore 001067 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
JW Pharmaceutical Corp Cash Flow Reinvestment Rate (2014–2024)
Historical reinvestment intensity for JW Pharmaceutical Corp across 10 annual periods. Also explore 001067 current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for JW Pharmaceutical Corp (2014–2024)
Year-by-year capital reinvestment analysis for JW Pharmaceutical Corp. For live market cap and broader valuation context, see JW Pharmaceutical Corp stock valuation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.75x | ₩59.86 Billion | ₩79.39 Billion | ₩28.14 Billion | ▼ -37.1% |
| 2023 | 1.20x | ₩104.49 Billion | ₩87.16 Billion | ₩40.71 Billion | ▲ +87.7% |
| 2022 | 0.64x | ₩36.26 Billion | ₩56.76 Billion | ₩9.92 Billion | ▲ +35.5% |
| 2021 | 0.47x | ₩8.55 Billion | ₩18.12 Billion | ₩7.47 Billion | ▼ -60.0% |
| 2020 | 1.18x | ₩74.34 Billion | ₩63.05 Billion | ₩12.39 Billion | ▲ +529.0% |
| 2019 | 0.19x | ₩10.41 Billion | ₩55.53 Billion | ₩9.28 Billion | ▼ -29.3% |
| 2018 | 0.27x | ₩13.82 Billion | ₩52.11 Billion | ₩8.64 Billion | ▲ +17.9% |
| 2017 | 0.22x | ₩7.52 Billion | ₩33.45 Billion | ₩7.50 Billion | ▼ -91.9% |
| 2016 | 2.79x | ₩18.79 Billion | ₩6.74 Billion | ₩10.02 Billion | ▲ +131.2% |
| 2014 | 1.21x | ₩8.78 Billion | ₩7.28 Billion | ₩6.93 Billion | — |